Whats new
Whats new.
Maxim - Positive Median Overall Survival Data for Efti + Keytruda in 1L H&N Cancer - Rated Buy, US$12 PT (Analyst: Jason McCarthy, Ph.D.)
May 5th 2025
For a copy of this analyst report please contact your Maxim advisor
Whats new
May 5th 2025
For a copy of this analyst report please contact your Maxim advisor